Faculty, ACTREC-TMC, Navi Mumbai, India Interest: Tumor-microenvironment, Cancer-Associated Fibroblasts (CAFs) PhD @IIScBangalore, Postdoc at @WeizmannScience
Mumbai
Joined August 2019
- Tweets506
- Following267
- Followers294
- Likes1.7K
Pinned Tweet
I am glad to be part of this collaborative project. This study reveals how "TP53 mutations can influence fibrosis and the immune microenvironment in PDAC".
pnas.org/content/118/23/e202…
Sharath Chandra Arandkar retweeted
The wait is over — NRSM 2026 dates are here! 2–4 December 2026. hosted by ACTIIN Alliance. #nrsm2026 #nationalresearch #phdlife #phdstudent #mscstudent #cancerresearch #scicomm #indianscience #lablife #daterelease #nccs #iitbombay #tifrmumbai #iiserpune #mumbaiuniversity
Sharath Chandra Arandkar retweeted
China is putting scientists on giant screens in public places.
In India, our hoardings are dominated by politicians and film stars.
What we celebrate shapes what our children aspire to become. Why not put our scientists, teachers, doctors, innovators and nation-builders up there?
Sharath Chandra Arandkar retweeted
Hearty welcome to @ShivDoesScience
Our new faculty addition!!!
Shivani is a chemical biologist whose lab focuses on developing antibody-engineering platforms combined with peptide chemistry to probe cell surface protein function in cancer.
@biopatrika
Sharath Chandra Arandkar retweeted
Dr. Gunjan Mandal’s career highlights a particular focus on malignancies in women, such as breast, ovarian, & endometrial cancers, with a remarkable publications in Immunity, Cancer Research, Nature, Science, Cancer Cell, Journal of Immunology, JCI etc
Sharath Chandra Arandkar retweeted
We are happy to welcome our new faculty, Dr. Malay Kumar Sannigrahi at @CRI_ACTREC
His lab aims to uncover the metabolic camouflage that cancer cells use to hide from the immune system. actrec.gov.in/dr-malay-kumar…
@biopatrika
@VoicesofIndAcad @ACTREC_TMC
Sharath Chandra Arandkar retweeted
We welcome our new faculty Dr. Amartya Singh to @CRI_ACTREC
Amartya is a computational biologist and his lab focuses on the development of novel computational toolkits for improving single-cell and spatial transcriptomics data analysis!
Sharath Chandra Arandkar retweeted
Pleased to share an imp study on AI resistance in HR+ breast cancer--led by Suhail in my lab @UnivofDelhi & @CRI_ACTREC! We show insulin sig' mutations, ESR1 upreg', and a novel ESR1-PPP3CA fusion: new therapies to overcome resistance. Thanks @DBTIndia sciencedirect.com/science/ar…
Sharath Chandra Arandkar retweeted
Suhail's study from @amtdutt lab is out now!
Please read on to learn more!
Endocrine resistance in HR+ breast cancer
@ACTREC_TMC @biopatrika
Pleased to share our study led by @Suhail_Shaad on endocrine resistance in HR+ breast cancer @UnivofDelhi & @CRI_ACTREC. Loss of CDKN1B (p27) disrupts ER signaling, drives resistance, yet tumors retains sensitivity to CDK4/6 inhibitors. Thanks @DBTIndia
nature.com/articles/s41416-0…
Sharath Chandra Arandkar retweeted
Ph.D applications at @UnivofDelhi is open. Last date for applying is Mar 24th. You may register and apply here: phd-ph2-2025.uod.ac.in/index…
Last few days to apply for Mizuho #postdoctoral fellowship @CRI_ACTREC. Last date: 17th February. Email me for more details [email protected] #tumormicroenvironment #cancerresearch
Our lab is inviting applications for the Mizuho Postdoctoral Fellowship 🔬 Focus: Tumor microenvironment in lung & Pancreatic cancers @CRI_ACTREC, Navi Mumbai. Email: [email protected]
#PostdoctoralFellow #TumorMicroenvironment #CancerResearch @biopatrika
Thrilled to attend the EMBO Workshop on "Cancer in Young Adults" Excited to present our latest work at this important meeting and eager to learn more #EMBO #CancerResearch
Sharath Chandra Arandkar retweeted
Our lab is inviting applications for the Mizuho Postdoctoral Fellowship 🔬 Focus: Tumor microenvironment in lung & Pancreatic cancers @CRI_ACTREC, Navi Mumbai. Email: [email protected]
#PostdoctoralFellow #TumorMicroenvironment #CancerResearch @biopatrika
Our lab is inviting applications for the Mizuho Postdoctoral Fellowship 🔬 Focus: Tumor microenvironment in lung & Pancreatic cancers @CRI_ACTREC, Navi Mumbai. Email: [email protected]
#PostdoctoralFellow #TumorMicroenvironment #CancerResearch @biopatrika
Our Lab @CRI_ACTREC is supporting postdoctoral applications for the #NPDF 2026 scheme in the field of tumour microenvironment and cancer-associated fibroblasts. For details, reach out: [email protected]
#CancerResearch #TumorMicroenvironment #Biopatrika
𝗖𝗮𝗹𝗹 𝗳𝗼𝗿 𝗣𝗿𝗼𝗽𝗼𝘀𝗮𝗹𝘀 | 𝗔𝗡𝗥𝗙–𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗣𝗼𝘀𝘁𝗱𝗼𝗰𝘁𝗼𝗿𝗮𝗹 𝗙𝗲𝗹𝗹𝗼𝘄𝘀𝗵𝗶𝗽 (𝗡𝗣𝗗𝗙) 𝟮𝟬𝟮𝟲
𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗶𝗻𝗱𝗼𝘄: 15 Jan. – 17 Feb. 2026
𝗙𝗼𝗿 𝗱𝗲𝘁𝗮𝗶𝗹𝘀: anrfonline.in
#ANRFIndia #NPDF2026
Sharath Chandra Arandkar retweeted
Join us for an exciting day of Tumor Microenvironment with amazing speakers and lots of opportunities to interact, present your work and hear the latest discoveries 🤩
Still time to register in the following link conferences.weizmann.ac.il/S…
Sharath Chandra Arandkar retweeted
Interested and eligible candidates please apply
Are you curious about the complexities of #Cancer? Do you think #AI #BigData #Biotech can helps us understand #Biology of cancer? Apply: forms.gle/wKhwCUuLuwVRom9q8
Computational or basic biologists are welcome to apply.
BYOC #BringYourOwnCuriosity
@CRI_ACTREC @ACTREC_TMC
Looking forward to attend Dr.Siddhartha Mukherjee's talk...
The author of "The Emperor of all maladies" - Siddharatha Mukherjee visits us tomorrow and will deliver a talk on campus in our Tuesday Academic meeting! Excited & looking forward :)
@biopatrika @ACTREC_TMC @CRI_ACTREC
Sharath Chandra Arandkar retweeted
The author of "The Emperor of all maladies" - Siddharatha Mukherjee visits us tomorrow and will deliver a talk on campus in our Tuesday Academic meeting! Excited & looking forward :)
@biopatrika @ACTREC_TMC @CRI_ACTREC
Sharath Chandra Arandkar retweeted
Meet the Distinguished Speakers for NRSM'25: Dr.Banerjee (@iitbombay, Bacterial Pathogenesis), Dr.Sachdeva (@icmrnirrch, Endometrial function), Prof.Koushika (@TIFRScience, Synaptic transport) and Prof.Palakodeti (@DBT_inStem, RNA/Stem Cells).
Delighted to welcome our speakers!
Thrilled to share my first student Ghanapriya’s (@GhanaP10) work! Our study shows IGFBPs are central to sustaining CAF phenotype & driving heterogeneity in Tumor microenvironment. biorxiv.org/content/10.64898…. #CancerResearch #CAF #IGFBP. We thank @ANRF @DBT @CRI_ACTREC for funding.
